Streptomyces albulus Routien (ATCC® 12757)

Strain Designations: BA 4105 [CBS 711.72, IFO 13410, ISP 5492, RIA 1371]  /  Type Strain: yes  /  Biosafety Level: 1

Strain Designations BA 4105 [CBS 711.72, IFO 13410, ISP 5492, RIA 1371]
Produces 3-[2-(5-acetoxy-2-hydroxy-3,5-dimethyl-cyclohexyl)-2-hydroxyethyl] glutarimide
Production of 3-[2-(5-acetoxy-2-hydroxy-3,5- dimethyl-cyclohexyl)-2-hydroxyethyl] glutarimide and derivatives
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain yes (type strain)
Medium ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor Chas. Pfizer & Co., Inc.

Rao KV. 3-[2-(5-acetoxy-2-hydroxy-3,5-dimethyl cyclohexyl)-2-hydroxyethyl] glutarimide and derivatives thereof. US Patent 3,095,418 dated Jun 25 1963

Shirling EB, Gottlieb D. Cooperative description of type strains of Streptomyces. V. Additional descriptions. Int J Syst Bacteriol 22: 265-394, 1972.

Rao KV, Cullen WP. E-73: An antitumor substance. Part I. Isolation and characterization. J. Am. Chem. Soc. 82: 1127-1128, 1960.

Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980.

type strain

type strain